Local NewsBusiness Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with Relapsed/Refractory B-Cell Lymphoma By Digital AIM Web Support - February 24, 2021 FacebookTwitterPinterestWhatsApp Like this:Like Loading... Related Featured Local Savings Featured Local Savings